Clinical Trials
Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, announced patient dosing in its ongoing Phase 1b/2a IMX-110 monotherapy...
Clinical Trials
By 2027, Market For Oligonucleotides Will Be Worth $16.7 Bn
The growth in ongoing clinical trials for oligonucleotide-based therapies in important therapeutic fields like oncology is expected to cause the global oligonucleotide synthesis market to...
Clinical Trials
A Multi-Drug Trial On Cancer Precision Medicine Has Begun
A multi-drug, precision medicine trial involving Roche, the University of Manchester, and Cancer Research UK has begun for patients with rare cancers who need additional...
Clinical Trials
Digital Trials Evolving Due To Single, Connected Foundation
Clinical trials have expanded from 2,119 in 2000 to over 409,000 in 2022 (and counting). Not only has the number of trials increased, but so...
Clinical Trials
NICE Offers Historical Clinical Funding To Kidney Cancer UK
Through its approach to NHS England, the non-profit organisation Kidney Cancer UK was able to gain funding for the National Institute for Health and Care...
Clinical Trials
Edible Sensor Monitors HIV Patients Antiretroviral Doses
A new ingestible sensor system that was put to the test in an interventional clinical trial gave HIV patients real-time antiretroviral dosage information, helping them...
Clinical Trials
A New Initiative To Assess Clinical Trials Carbon Footprint
The Clinical Trials Environmental Impact Community of Interest (CoI), a cooperative effort that aims to determine the carbon footprint of centralised and decentralised clinical trials,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.